Integrated Diagnostics : Presentation for 9M2023 results

IDH Results Presentation

November 2023

Table of

Contents

IDH At a Glance

9M 2023 Results Overview

Key Investment Highlights

Our Market

Our Business Model

Financial Position and Performance

Growth Strategies

Governance

Who We Are (I/II)

Integrated Diagnostics Holding is a leading, fully-integrated provider of high-quality medical diagnostic services with a

footprint spanning Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia

An integrated diagnostics provider…

Pathology

Radiology

Immunology

Microbiology

Haematology

Endocrinology

PET-CT

Mammography

Electromyography

MRI

Ultrasound

Electroencephalography

Clinical

Molecular

Parasitology

Histopathology

Genetics

CT

X-Ray

Electrocardiogram

Chemistry

Biology

…with a suite of internationally-accredited,market-leading brands

Our Brands

Our Accreditations

21%

Shareholding

52%

Structure

27%

Hena Holdings Ltd

Actis IDH B.V.

Free Float

3 INTEGRATED DIAGNOSTICS HOLDINGS

Who We Are (II/II)

The Company's reach, scale, and service quality are unmatched across its markets of operation

Track Record

+40 years

First lab established in 1979

Patients

c.10 MN

Per year

Tests

c.30 MN

Per year

Market Reach

Over 594 Branches

As at 30 September 2023

Accreditations

Sole CAP & ACR

Accredited lab and scan in Africa

Test Portfolio

+3,000

Tests

Dual-listing

LSE in 2015 | EGX in 2021

Nigeria

Sustainable Growth

20%

Revenue CAGR 2015-22

Jordan

Egypt

Saudi

Arabia

Sudan

4 INTEGRATED DIAGNOSTICS HOLDINGS

Our Service Segments

IDH's pathology offering currently contributes the lion share of revenue and patients. The Company's radiology services

are quickly gaining momentum with their contribution to IDH's top-line doubling in the last twelve months

Pathology - 94% of Revenues1

Radiology - 6% of Revenues1,2

Through IDH's brands, the Group offers over 2,000 internationally

IDH offers a vast array of radiology services through Al Borg Scan in Egypt

accredited pathology tests ranging from basic blood glucose tests for

and Echo-Lab in Nigeria. Al Borg Scan is also the sole radiology provider

diabetes to advanced molecular testing for genetic disorders.

in Africa boasting the prestigious American College of Radiology (ACR)

accreditation, a testament to the high-quality services delivered by the

venture.

575

1979

c. 10mn

c. 30mn

19

2018

c. 1.1mn

c. 1.8mn

Pathology

Year

Patients served

Tests performed

Radiology

Year

Patients served

Scans conduced

branches

launched

each year

each year

branches

launched

since inception

since inception

Competitive Strengths

Competitive Strengths and Strategic Advantages

Visibility and

Scalable

Diversify and

Deliver on one-

Track

Reach and

Established

High-fragment

Record

scale across

Reputation

Business

platform to

and fast-

Grow Revenue

stop-shop

attractive

Model

build on

growing market

Streams

vision

markets

An integrated offering catering to patients' evolving needs

1. Share of IDH 9M 2023 consolidated revenue.
2. Radiology revenues are calculated as Echo-Lab (IDH's Nigerian subsidiary) revenues plus Al-Borg Scan revenues (Egypt's radiology business).

5 INTEGRATED DIAGNOSTICS HOLDINGS

Our Geographies

IDH currently operates the largest branch network amongst private providers in Egypt and boasts an established

presence in four key markets in the Middle East and Africa

Egypt		Jordan		Nigeria	Sudan

1979

537

2011

27

2018

12

2011

18

First began

Branches (51% in

Acquisition

Branches

Acquisition of Echo-

Branches

Acquisition of Ultra

Branches

operations

Cairo Region)

of Biolab

Lab

Lab

#1

82%

#1

15%

Top 5

3%

#1

0.4%

Market Ranking1 (#1

Share of consolidated

Market Ranking1

Share of consolidated

Market Ranking

Share of consolidated

Market Ranking1

Share of consolidated

in Corporate

revenues in 9M 2023

revenues in 9M 2023

revenues in 9M 2023

revenues in 9M 2023

Insurance Sector)

5.8 mn

24.4 mn

286 k

1.9 mn

102 k

204 k

14 k

40 k

Patients served

Tests performed

Patients served

Tests performed

Patients served

Tests performed

Patients served

Tests performed

in 9M 2023

in 9M 2023

in 9M 2023

in 9M 2023

in 9M 2023

in 9M 2023

in 9M 2023

in 9M 2023

1 Market ranking amongst private players in each respective country.

6 INTEGRATED DIAGNOSTICS HOLDINGS

Our Patients

IDH serves two principal types of patients: contract and walk-in

Around 70% of total revenue generated across the two segments is paid in cash

Contract Patients1		Walk-In Patients

IDH's contract clients include institutions who enter into one-year renewable contracts at agreed rates per-testand on a per-clientbasis. Around 40% of the revenue generated by the segment is paid in cash. IDH's corporate clients roster currently features institutions such as:

• Unions
• Syndicates
• Private and public insurance companies
• Banks and corporations
• Public institutions
• Government insurance

IDH's walk-in clients, also referred to as "self-payers",pay out of pocket for diagnostic tests and other services.

Contribution to IDH Revenues (9M 2023)

37% EGP

3,054

mn 63%

	Contract Revenues		Walk-in Revenues

1 Testing prices at the contract segment are generally lower than those of the walk-in segment and are not pre-set as with walk-in testing

7 INTEGRATED DIAGNOSTICS HOLDINGS

Patient Split by Segment (9M 2023)

21%

6.2 mn

patients

79%

Contract Patients		Walk-in Patients

IDH Post Covid-19 : A new chapter (I/II)

During the Covid-19 era, IDH successfully transformed its business, expanding its service offering and delivery

capabilities, and setting the foundation for a new chapter of sustainable growth, testament to its business agility and

resilience

Test Offering and Delivery	Reach and Visibility	Agility
Conventional Business Back to Pre-	Ramped up	Ramped Up House Call	Growing Physical	Rapid Service Offering Adaptation
Covid Levels	House Call Services	Capacity	Presence

+91%		16%
Growth in conventional test1	House call contribution to
	revenue vs 9M 2019	Egypt revenues in 1H 2023
			(exceeding pre-pandemic
			averages of 10-11%)

	up to 5k	+50	#1	#1		#1
House call visits per day, with	New branches opened		in PCR testing in	leading PCR testing	for house call
over 10k calls answered daily	during the last 12-month		Egypt and first to		provider in Jordan	volumes in Egypt
			period		offer QR codes

Frontline Role in Fight Against

Covid-19

9.0 mn

Covid tests performed in

Egypt and Jordan

(2020-2022)

Al-Borg Scan

Expansion

7

Operational Branches as at

30 September 2023 (fastest

growing radiology brand in

Egypt)

New Patient		Largest Private Provider	Ample Capacity for Growth
Segments		in Egypt
c. 5 mn	594		5-7 yrs.	40%
New patients acquired		Operational Branches as at	Average contract tenors for	Spare processing capacity in
during Covid-19-pandemic	30 June 2023 (537 branches	equipment		Mega Lab
(2020-2022)		in Egypt)

A patient-centric business geared for long-term, sustainable growth

1 Convention tests refers to IDH's service offering excluding all Covid-19-related testing performed during the period.

8 INTEGRATED DIAGNOSTICS HOLDINGS

IDH Post Covid-19: A new chapter (II/II)

During the Covid-19 era, IDH successfully transformed its business, expanding its service offering and delivery

capabilities, and setting the foundation for a new chapter of sustainable growth, testament to its business agility and

resilience

Improved Efficiency

Long-term Relationships

Decreased Turnaround Times and Improved Patient Satisfaction

over 80%		max 24hr
Net Promoter Score (NPS)		Turn-around time

Expanded Digital Capabilities

over 5k Chatbot conv/day		Convenient Payments
Diversifying patient touch-points	Leveraging expanded digital presence

Revamped Loyalty Programme

In partnership with leading loyalty solutions provider to retain existing/new

patients acquired in 2022

Expanded Cross-selling Capabilities

Monitoring patient records and disease cycles to provide tailored services

and increase cross-selling

Marketing Strategy

Visibility bolstered by additional marketing efforts throughout the year including

launch of new IDH branded cars as well as greater social media presence

A patient-centric business geared for long-term, sustainable growth

1 Convention tests refers to IDH's service offering excluding all Covid-19-related testing performed during the period.

9 INTEGRATED DIAGNOSTICS HOLDINGS

9M 2023 Results Overview